Energy stress-induced dopamine loss in glutathione peroxidase- overexpressing transgenic mice and in glutathione-depleted mesencephalic cultures

Journal of Neurochemistry

Volumn 68, Issue 1, 1997, Pages 426-429

  Zeevalk, Gail D ^a   Bernard, Laura P ^a   Albers, David S ^a   Mirochnitchenko, Oleg ^b   Nicklas, William J ^a   Sonsalla, Patricia K ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b Department of Biochemistry ^*  (United States)

Author keywords

Energy metabolism; Oxidative stress; Parkinson's disease

Indexed keywords

DOPAMINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; DOPAMINERGIC NERVE CELL; ENERGY EXPENDITURE; MESENCEPHALON; MOUSE; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL;

ANIMALIA; MUS MUSCULUS;

EID: 0031025395     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68010426.x     Document Type: Article

References (34)

1. Albers D. S., Zeevalk G. D., and Sonsalla P. K. (1996) Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP. Brain Res. 718, 217-220.
2. Beal M. F. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31, 119-130.
3. Beal M. F., Brouillet E., Jenkins B., Henshaw R., Rosen B., and Hyman B. T. (1993) Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J. Neurochem. 61, 1147-1150.
4. Beal M. F., Ferrante R. J., Henshaw R., Matthews R. T., Chan P. H., Kowall N. W., Epstein C. J., and Schulz J. B. (1995) 3-Nitropropionic acid neurotoxicity is attenuated in coppers/zinc superoxide dismutase transgenic mice. J. Neurochem. 65, 919-922.
5. Berman S. B., Zigmond M. J., and Hastings T. G. (1996) Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J. Neurochem. 67, 593-600.
6. Bhave S. V., Johannessen J. N., Lash L. H., Wakade T. D., and Wakade A. R. (1996) Age-dependent sensitivity of cultured peripheral sympathetic neurons to 1-methyl-4-phenylpyridinium: role of glutathione. J. Neurochem. 67, 557-565.
7. Boveris A. and Chance B. (1973) The mitochondrial generation of hydrogen peroxide. Biochem. J. 134, 707-716.
8. Brannan T. S., Maker H. S., Weiss C., and Cohen G. (1980) Regional distribution of glutathione peroxidase in the adult rat brain. J. Neurochem. 35, 1013-1014.
9. Brouillet E., Jenkins B. G., Hyman B. T., Ferrante R. J., Kowall N. W., Srivastava R., Roy D. S., Rosen B. R., and Beal M. F. (1993) Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J. Neurochem. 60, 356-359.
10. Coyle J. T. and Puttfarcken P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-694.
11. Flohe L. and Gunzler W. (1984) Assays of glutathione peroxidase. Methods Enzymol. 105, 114-121.
12. Giovanni A., Sieber B.-A., Heikkila R. E., and Sonsalla P. K. (1994) Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration. J. Pharmacol. Exp. Ther. 270, 1000-1007.
13. Graham D. G. (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14, 633-643.
14. Greene J. G. and Greenamyre J. T. (1995) Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate. J. Neurochem. 64, 430-436.
15. Hastings T. G. (1995) Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J. Neurochem. 64, 919-924.
16. Hogan B. L. M., Constantini F., and Lacy E. (1986) Manipulating the Mouse Embryo. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
17. Kish S. J., Morito C., and Hornykiewicz O. (1985) Glutathione peroxidase activity in Parkinson's disease brain. Neurosci. Lett. 58, 343-346.
18. Ludolph A. C., Seelig M., Ludolph A., Novitt P., Allen C. N., Spencer P. S., and Sabri M. I. (1992) 3-Nitropropionic acid decreases cellular energy levels and causes neuronal degeneration in cortical explants. Neurodegeneration 1, 155-161.
19. Mirochnitchenko O., Palnitkar U., Philbert M., and Inouye M. (1995) Thermosensitive phenotype of transgenic mice overproducing human glutathione peroxidase. Proc. Natl. Acad. Sci. USA 92, 8120-8124.
20. Oyanagui Y. (1984) Reevaluation of assay methods and establishment of a kit for superoxide dismutase activity. Anal. Biochem. 142, 290-296.
21. Perry T. L. and Yong V. W. (1986) Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci. Lett. 67, 269-274.
22. Philbert M. A., Beiswanger C. M., Waters D. K., Reuhl K. R., and Lowndes H. E. (1991) Cellular and regional distribution of reduced glutathione in the nervous system of the rat: histochemical localization by mercury orange and o-phthaldialdehyde-induced histofluorescence. Toxicol. Appl. Pharmacol. 107, 215-227.
23. Przedborski S., Kostic V., Jackson-Lewis V., Naini A. B., Simonetti S., Fahn S., Carlson E., Epstein C. J., and Cadet J. L. (1992) Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12, 1658-1667.
24. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V. L., and Dawson T. M. (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA. 93, 4565-4571.
25. Sagara J., Miura K., and Bannai S. (1993) Maintenance of neuronal glutathione by glial cells. J. Neurochem. 61, 1672-1676.
26. Schulz J. B., Huang P. L., Matthews R. T., Passov D., Fishman M. C., and Beal M. F. (1996) Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice. J. Neurochem. 67, 430-433.
27. Sian J., Dexter D. T., Lees A. J., Daniel S., Jenner P., and Marsden C. D. (1994) Glutathione-related enzymes in brain in Parkinson's disease. Ann. Neurol. 36, 356-361.
28. Slivka A., Mytilineou C., and Cohen G. (1987a) Histochemical evaluation of glutathione in brain. Brain Res. 409, 275-284.
29. Slivka A., Spina M. B., and Cohen G. (1987b) Reduced and oxidized glutathione in human and monkey brain. Neurosci. Lett. 74, 112-118.
30. Sonsalla P. K., Riordan D. E., and Heikkila R. E. (1991) Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J. Pharmacol. Exp. Ther. 256, 506-512.
31. Spina M. B., and Cohen G. (1989) Dopamine turnover and glutathione oxidation: implications for Parkinson's disease. Proc. Natl. Acad Sci. USA 86, 1398-1400.
32. Traystman R. J., Kirsch J. R., and Koehler R. C. (1991) Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J. Appl. Physiol. 71, 1185-1195.
33. Zeevalk G. D., Derr Yellin E., and Nicklas W. J. (1995a) Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade. J. Pharmacol. Exp. Ther. 275, 1124-1130.
34. Zeevalk G. D., Derr-Yellin E., and Nicklas W. J. (1995a) NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid. J. Neurochem. 64, 455-458.